The licenses are royalty-free until the World Health Organization declares the end of the public health emergency regarding Covid-19
13 May 2020 8:44 AM
Shares of the company declined as much as 7.7 per cent, in their sharpest intraday drop since November 2017.
05 Nov 2018 2:44 PM
Cipla in a BSE filing said it has received final approval from USFDA for tenofovir disoproxil fumarate tablets.
31 Jan 2018 8:49 AM
Cipla’s stock was down 5.6 per cent in Indian market that was 0.96 per cent lower.
07 Nov 2017 4:57 PM
The company will soon start looking for partners for its existing biosimilars programme, CEO Umang Vohra said at a press conference.
26 May 2017 11:22 AM
The acquisition is expected to be completed by March 2017 subject to completion of precedent conditions and regulatory approvals.
15 Dec 2016 12:14 PM